Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling

Slides:



Advertisements
Similar presentations
Volume 11, Issue 3, Pages (March 2012)
Advertisements

Yujiao Yang, Chao Shan, Jing Zou, Antonio E
Volume 19, Issue 6, Pages (June 2016)
Volume 28, Issue 5, Pages (May 2008)
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 8, Issue 1, Pages (July 2014)
Volume 17, Issue 3, Pages (March 2015)
Volume 21, Issue 2, Pages (February 2017)
Volume 11, Issue 3, Pages (March 2012)
The Interferon-Inducible MxB Protein Inhibits HIV-1 Infection
Volume 6, Issue 5, Pages (November 2009)
Volume 21, Issue 11, Pages (December 2017)
Volume 11, Issue 6, Pages (June 2012)
Cellular DDX21 RNA Helicase Inhibits Influenza A Virus Replication but Is Counteracted by the Viral NS1 Protein  Guifang Chen, Chien-Hung Liu, Ligang.
Volume 22, Issue 1, Pages e4 (July 2017)
DAI/ZBP1/DLM-1 Complexes with RIP3 to Mediate Virus-Induced Programmed Necrosis that Is Targeted by Murine Cytomegalovirus vIRA  Jason W. Upton, William J.
Volume 16, Issue 1, Pages (July 2014)
Volume 22, Issue 3, Pages e5 (September 2017)
Brian Yordy, Norifumi Iijima, Anita Huttner, David Leib, Akiko Iwasaki 
Volume 1, Issue 1, Pages (March 2007)
DEPARTMENT OF ERROR The Lancet Volume 362, Issue 9385, (August 2003)
The Nogo Receptor NgR1 Mediates Infection by Mammalian Reovirus
Volume 8, Issue 6, Pages (December 2010)
Volume 10, Issue 3, Pages (September 2011)
A Mouse Model of Zika Virus Pathogenesis
Volume 10, Issue 3, Pages (September 2009)
Volume 18, Issue 2, Pages (August 2015)
Volume 20, Issue 5, Pages (November 2016)
Volume 22, Issue 4, Pages e5 (October 2017)
Phospholipid Scramblase 1 Mediates Type I Interferon-Induced Protection against Staphylococcal α-Toxin  Miroslaw Lizak, Timur O. Yarovinsky  Cell Host.
Volume 22, Issue 1, Pages e7 (July 2017)
TET3 Inhibits Type I IFN Production Independent of DNA Demethylation
Volume 18, Issue 1, Pages (July 2015)
Glycogen Synthase Kinase 3β Regulates IRF3 Transcription Factor-Mediated Antiviral Response via Activation of the Kinase TBK1  Cao-Qi Lei, Bo Zhong, Yu.
Volume 5, Issue 1, Pages (January 2009)
Volume 12, Issue 2, Pages (August 2012)
Mouse STAT2 Restricts Early Dengue Virus Replication
Volume 30, Issue 3, Pages (March 2009)
Volume 16, Issue 3, Pages (September 2014)
Volume 21, Issue 4, Pages e4 (April 2017)
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Volume 18, Issue 6, Pages (December 2015)
Zika Virus Infects Human Placental Macrophages
Volume 16, Issue 6, Pages (December 2014)
Volume 17, Issue 6, Pages (June 2015)
Volume 5, Issue 2, Pages (February 2009)
Melissa B. Uccellini, Adolfo García-Sastre  Cell Reports 
Volume 20, Issue 4, Pages (October 2016)
Volume 9, Issue 4, Pages (April 2011)
Poxviral B1 Kinase Overcomes Barrier to Autointegration Factor, a Host Defense against Virus Replication  Matthew S. Wiebe, Paula Traktman  Cell Host.
Volume 5, Issue 5, Pages (May 2009)
Volume 21, Issue 6, Pages (November 2017)
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Inside Job: Viruses Transfer cGAMP between Cells
Volume 40, Issue 4, Pages (April 2014)
Volume 3, Issue 1, Pages (January 2013)
Volume 25, Issue 10, Pages e8 (December 2018)
Volume 9, Issue 2, Pages (February 2011)
Volume 68, Issue 2, Pages e4 (October 2017)
Volume 28, Issue 5, Pages (May 2008)
Volume 20, Issue 2, Pages (August 2016)
Viperin Poisons Viral Replication
Regulation of KSHV Lytic Switch Protein Expression by a Virus-Encoded MicroRNA: An Evolutionary Adaptation that Fine-Tunes Lytic Reactivation  Priya Bellare,
Volume 14, Issue 1, Pages (July 2013)
Volume 41, Issue 3, Pages (February 2011)
Volume 38, Issue 3, Pages (March 2013)
Volume 31, Issue 5, Pages (September 2008)
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Volume 20, Issue 2, Pages (August 2016)
Volume 11, Issue 6, Pages (June 2012)
Presentation transcript:

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling Alesha Grant, Sanket S. Ponia, Shashank Tripathi, Vinod Balasubramaniam, Lisa Miorin, Marion Sourisseau, Megan C. Schwarz, Mari Paz Sánchez-Seco, Matthew J. Evans, Sonja M. Best, Adolfo García-Sastre  Cell Host & Microbe  Volume 19, Issue 6, Pages 882-890 (June 2016) DOI: 10.1016/j.chom.2016.05.009 Copyright © 2016 Elsevier Inc. Terms and Conditions

Cell Host & Microbe 2016 19, 882-890DOI: (10.1016/j.chom.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 1 Phylogenetically Diverse NS5 Proteins Antagonize Type I IFN Signaling (A) Phylogenetic tree of NS5 proteins; red indicates proteins chosen for characterization. (B) Amino acid percent identity matrix of NS5 proteins. (C) ISG54 reporter assay performed in triplicate in 293T cells transfected with increasing amounts of NS5 plasmids. (D) Renilla luciferase values for (C). (E) Immunoblot of 293T cells transfected with GFP and flavivirus NS5 plasmids. GFP-positive cells of similar intensity were sorted by flow cytometry. (F) HA-tag IP assay and immunoblot of 293T cells transfected with indicated HA-tagged plasmids. (G) Vero cell IFA for endogenous STAT2 levels post-IFN treatment for 30 min. (H) Same as (G), except staining for endogenous pSTAT1. Error bars represent mean ± SD. Results are representative of three or more independent experiments. Cell Host & Microbe 2016 19, 882-890DOI: (10.1016/j.chom.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 2 ZIKV NS5 Proteins Antagonize Type I IFN Signaling by Targeting STAT2 (A) ISG54 reporter assay performed in triplicate in 293T cells transfected with increasing amounts of NS5-expressing plasmids. (B) HA-tag IP assay and immunoblot of 293T cells transfected with indicated HA-tagged plasmids. (C) Immunoblot of 293T cells transfected with increasing amounts of DENV2, ZIKV UG, and FP NS5 plasmids. (D) Vero cell IFA for co-localization of overexpressed human STAT2-FLAG and ZIKV NS5-HA-tagged proteins. (E) Vero cell IFA of endogenous STAT2 levels post-IFN treatment for 30 min. Error bars represent mean ± SD. Results are representative of three or more independent experiments. Cell Host & Microbe 2016 19, 882-890DOI: (10.1016/j.chom.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 3 ZIKV Degrades STAT2 in a Proteasome-Dependent Manner (A) Vero cell IFA of endogenous STAT2 upon ZIKV UG infection and IFN treatment for 30 min. (B) qRT-PCR analysis of ISGs and ZIKV UG RNA upon infection in Vero cells for 24 hr at indicated MOI, following mock treatment or treatment with IFN for 14 hr. nd, not detected; error bars represent mean ± SD of triplicates. (C) Immunoblot of Vero cells infected with ZIKV UG or ZIKV PR for 24 hr at indicated MOI. (D) Immunoblot of 293T cells infected with DENV2 and ZIKV UG followed by mock, MG132 (MG), or Lactacystin (LC) proteasome inhibitor treatment. (E) Immunoblot of DENV2- and ZIKV UG-infected wild-type 293T or Ubr4-deficient 293T cells, 24 hr post-infection at MOI 5. (F) HA-tag IP assay and immunoblot of 293T cells transfected with indicated HA-tagged plasmids. Results are representative of three or more independent experiments. Cell Host & Microbe 2016 19, 882-890DOI: (10.1016/j.chom.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions

Figure 4 ZIKV Exhibits Species-Specific Antagonism of STAT2 (A) Vero cell IFA of viral NS5 and E proteins upon ZIKV Fortaleza infection at MOI 5 for 24 hr. (B) Vero cell IFA for co-localization between overexpressed mouse STAT2-FLAG and ZIKV UG NS5-HA-tagged proteins. (C) HA-tag IP assay and immunoblot analysis of 293T cells transfected with ZIKV UG NS5-HA, human STAT1-FLAG, human STAT2-FLAG, and mouse STAT2-FLAG plasmids. (D) Immunoblot of primary human and mouse fibroblasts infected with ZIKV Fortaleza strain at MOI 5 for indicated duration. (E) Measurement of ZIKV Fortaleza viral replication by plaque assay in primary human and mouse fibroblasts infected at MOI 0.1 for indicated duration. PFU, plaque-forming unit. (F) Immunoblot of wild-type (WT) and IFNAR−/− MEFs infected with ZIKV Fortaleza at MOI 1, probed with anti-NS5 sera. Results are representative of three or more independent experiments. Cell Host & Microbe 2016 19, 882-890DOI: (10.1016/j.chom.2016.05.009) Copyright © 2016 Elsevier Inc. Terms and Conditions